Clinical evidence for a graft-versus-tumour effect following allogeneic HSCT for t(8;13) atypical myeloproliferative disorder
Authors:
- 23 February 2009
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 44 (3) , 197-199
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Rapid transformation of atypical myeloproliferative disorder with consistent t(8;13) to B-cell acute lymphoblastic leukemia: A case reportHematology, 2007
- Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndromeBlood, 2007
- Long-term complete haematological and molecular remission after allogeneic bone marrow transplantation in a patient with a stem cell myeloproliferative disorder associated with t(8;13)(p12;q12)British Journal of Haematology, 2003
- The 8p11 Myeloproliferative Syndrome: A Distinct Clinical Entity Caused by Constitutive Activation of FGFR1Acta Haematologica, 2002
- Consistent Fusion of ZNF198 to the Fibroblast Growth Factor Receptor-1 in the t(8;13)(p11;q12) Myeloproliferative SyndromeBlood, 1998
- An atypical myeloproliferative disorder with t(8;13) (p11;q12): a third caseBritish Journal of Haematology, 1994